Barry Cherney
Impact in
- Immunology top 5%
- Biosimilars and Bioanalytical Methods
- Oncology top 5%
- PARP inhibition in cancer therapy
Papers in
-
- Protein purification and stability 6
- DNA Repair Mechanisms 6
- Oncology 21
- PARP inhibition in cancer therapy 11
- Viral-associated cancers and disorders 5
- Co-authors
- Giovanna Tosato (13 shared papers)Kishor Bhatia (12 shared papers)Amy S. Rosenberg (4 shared papers)Mark E. Smulson (10 shared papers)Ghanshyam Das Gupta (5 shared papers)Sandra E. Pike (5 shared papers)Daniela Verthelyi (2 shared papers)Julie Teruya‐Feldstein (3 shared papers)
- Journals
- Nucleic Acids Research (5 papers)Proceedings of the National Academy of Sciences (4 papers)Current Genetics (3 papers)Blood (3 papers)Journal of Pharmaceutical Sciences (2 papers)
- Partner nations
- United StatesItalyThailand
In The Last Decade
Barry Cherney
46 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 124
- Immunology 818
- Oncology 866
- Molecular Biology 1.6k
- Radiology, Nuclear Medicine and Imaging 366
- Cancer Research 217
Countries citing papers authored by Barry Cherney
This map shows the geographic impact of Barry Cherney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Cherney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Cherney more than expected).
Fields of papers citing papers by Barry Cherney
This network shows the impact of papers produced by Barry Cherney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Cherney. The network helps show where Barry Cherney may publish in the future.
Co-authors
The 25 scholars most cited alongside Barry Cherney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 440 | |
| 2 | 1998 | 247 | |
| 3 | 1996 | 187 | |
| 4 | 1999 | 160 | |
| 5 | 1987 | 155 | |
| 6 | 2007 | 111 | |
| 7 | 1993 | 105 | |
| 8 | 1988 | 84 | |
| 9 | 2012 | 83 | |
| 10 | Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment. | 1998 | 72 |
| 11 | 1994 | 69 | |
| 12 | 1987 | 67 | |
| 13 | 1989 | 63 | |
| 14 | The apoptosis-associated gamma-ray response of BCL-X(L) depends on normal p53 function. | 1996 | 58 |
| 15 | 1994 | 54 | |
| 16 | Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis. | 1999 | 52 |
| 17 | 2010 | 49 | |
| 18 | Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells. | 1997 | 44 |
| 19 | 1990 | 41 | |
| 20 | 2002 | 37 |
About Barry Cherney
Barry Cherney is a scholar working on Molecular Biology, Oncology, Immunology, Pathology and Forensic Medicine and Cancer Research, having authored 46 papers that have together received 2.6k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (11 papers), Protein purification and stability (6 papers), DNA Repair Mechanisms (6 papers), Toxin Mechanisms and Immunotoxins (6 papers), Viral-associated cancers and disorders (5 papers), Immune Cell Function and Interaction (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Biosimilars and Bioanalytical Methods (4 papers). The work is most often cited by research in Immunology (818 citations), Oncology (866 citations), Molecular Biology (1.6k citations), Radiology, Nuclear Medicine and Imaging (366 citations) and Cancer Research (217 citations). Barry Cherney has collaborated with scholars based in United States, Italy and Thailand. Frequent co-authors include Giovanna Tosato, Kishor Bhatia, Amy S. Rosenberg, Mark E. Smulson, Ghanshyam Das Gupta, Sandra E. Pike, Daniela Verthelyi, Julie Teruya‐Feldstein, Ellis Merlin and K Taga. Their work appears in journals such as Nucleic Acids Research, Proceedings of the National Academy of Sciences, Current Genetics, Blood and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.